<DOC>
	<DOCNO>NCT02044588</DOCNO>
	<brief_summary>To determine safety use kidney organ hepatitis B surface antigen positive donor , author conduct single-center , prospective study use kidney recipient protective level hepatitis B surface antibody .</brief_summary>
	<brief_title>Hepatitis B Antigen Kidney Graft Into Protective Level Hepatitis B Antibody Recipients</brief_title>
	<detailed_description>The kidney transplant registry conduct KCMH since year 2000 present . The inclusion criterion : - All kidney allograft recipient receive least one month transplantation . - All kidney recipient already protective antibody hepatitis B virus infection define anti-HBs titer 100 mIU/mL pre-transplantation period . The exclusion criterion : - The recipient positive hepatitis C virus antibody . - The recipient receive previous simultaneous non-kidney solid organ transplant . - The recipient lose follow-up . Study group : - The recipient receive kidney allograft HBsAg ( + ) donor . Control group : - The recipient receive kidney allograft HBsAg ( - ) donor . According Thai Red Cross National Organ Donation institute 's policy , HBsAg ( + ) kidney allograft distribute informed consent . Data collection : - Baseline characteristic data e.g . donor recipient age , donor recipient gender , HLA , PRA , anti-HBs titer , immunity HBV status ( natural vaccinate ) , immunosuppressive regimen collect . - The recipient prospective follow month 3 , 6 , 9 , 12 , 18 , 24 , 36 , 48 , 60 , 72 , 84 , 96 , 108 , 120 . - Clinical data include jaundice , hepatitis , graft rejection collect - Laboratory data HBsAg , anti-HBc , HBV DNA , SGOT , SGOT , eGFR collect . - Pathological data allograft biopsy month 12 24 retrieve . Outcomes : - Primary outcome : hepatitis B transmission rate . - Secondary outcome : graft survival , patient survival .</detailed_description>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Hepatitis B Antibodies</mesh_term>
	<criteria>The inclusion criterion : All kidney allograft recipient receive least one month transplantation . All kidney recipient already protective antibody hepatitis B virus infection define antiHBs titer 100 mIU/mL pretransplantation period . The exclusion criterion : The recipient positive hepatitis C virus antibody . The recipient receive previous simultaneous nonkidney solid organ transplant . The recipient lose followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>HBsAg ( + ) donor</keyword>
	<keyword>HBsAg ( - ) donor</keyword>
	<keyword>Anti-hepatitis B antibody</keyword>
	<keyword>Kidney allograft</keyword>
</DOC>